uvstocks.io

Today’s CSR movers

ETR 4.0 ▲ 1.5

SO 3.0 ▲ 1.0

NTAP 3.6 ▲ 0.5

PWR 4.6 ▲ 0.5

SNPS 4.6 ▲ 0.5

APA 3.1 ▲ 0.1

ITW 2.7 ▲ 0.1

CF 2.9 ▼ 0.1

VMC 3.7 ▼ 0.1

COO 3.6 ▼ 0.1

Health Care · NASDAQ NASDAQ · ALGN

Align Technology

$150.82 +$0.11 +0.07% CLOSE 09.11.26 AFTER HOURS $151.34

Convergence score

4.0 / 5.0 STRONG BULLISH

+0.0 vs last report

Overall valuation

Undervalued

Aggregated across multiple horizons

Consensus target (12mo)

$207.85 +37.8%

Range $150.00 — $240.00

Sector

Health Care

NASDAQ · Tracked daily

Today's snapshot

Where the signals stand.

REPORT 09.11.26

UV Convergence Score

REPORT 09.11.26

4.0

/ 5.0

STRONG BULLISH

Consensus signal A

4.0

Consensus signal B

4.0

Consensus signal D

4.0

Analyst average

4.1

Multi-signal aggregate How CSR works →

Day Range

$149.49 – $153.87

52W Range

$122.00 – $200.44

Volume

619.8K

Avg Vol

957.1K

Mkt Cap

$10.71B

P/E

26.18

EPS (TTM)

$5.76

Div Yield

—

Beta

1.64

Today's convergence

Convergence score sits at 4.0 with overall valuation reading as undervalued. Drivers across the horizons inform the aggregate. Open the deep dives for valuation, analyst, or financial detail.

Valuation

Undervalued

CSR direction

STRONG BULLISH

Last close

$150.82

Sector

Health Care

Valuation

Three horizons

UPDATED 09.11.26

Short term

0–3 MO

No target —

Medium term

3–12 MO

$206+36.8% Buy

Long term

12–36 MO

$184.47+22.3% Undervalued

Open valuation →

Analysts

Coverage & consensus

3 PANELS

Mean target (12mo)

$207.85 +37.8%

RANGE $150.00 — $240.00

Analyst consensus

Consensus rating Buy

Blended score 4.0 / 5

Analysts tracked 47

Open analysts →

Financials

Key metrics

LATEST

P/E

26.18

EPS (TTM)

$5.76

Mkt Cap

$10.71B

Div Yield

—

Beta

1.64

52W Range

$122.00 – $200.44

Open financials →

Reports

Valuation breakdown

Three horizons, one consensus.

UPDATED 09.11.26

Short term

0–3 MO

—

Consensus target

No target available

Medium term

3–12 MO

Buy

Consensus target

$206 +36.8%

RANGE $150 – $240

$150NOW $150.82$240

12-month analyst consensus target across covering brokerages.

Long term

12–36 MO

Undervalued

Consensus target

$184.47 +22.3%

UVStocks in-house sector-relative valuation model.

Signal breakdown

What’s driving the score.

EACH SIGNAL RATED 1.0 — 5.0

Top-level breakdown

Valuation:	PE Ratio: 26.18	PEG Ratio: -	DE Ratio: -
Free Cash Flow: $594.11M	PB Ratio: -	PS Ratio: -	Dividend: -

Analyst coverage

Blended analyst consensus & targets.

3 PANELS · UPDATED 09.11.26

Analyst consensus RATING · SCORE · PANELS · ANALYSTS

Rating Blended score Panels Analysts

Buy 4.0 3 47

Price targets LOW · MEAN · MEDIAN · HIGH · UPSIDE

Coverage Low Mean Median High Upside

All panels $150.00 $207.85 $209.00 $240.00 +37.8%

Rating distribution STRONG BUY · BUY · HOLD · SELL · STRONG SELL

Coverage SB B H S SS

All panels 4 16 11 0 1

Rating trend CURRENT VS 1M / 2M / 3M

Period Rating Avg Analysts

Current — — —

1 Mo Ago — — —

2 Mo Ago — — —

3 Mo Ago — — —

Most recent analyst action LATEST DESK ACTION

Date

9/4/2026

Firm

Weiss Ratings

Action

Upgrade

Rating

Hold (C-) ➝ Hold (C)

Target

—

Full financial snapshot.

UPDATED 09.11.26

Quote snapshot 15 FIELDS

Prev Close

$150.72

Open

$153.30

Day Low

$149.49

Day High

$153.87

Bid

$140.09

Ask

$163.31

52W Low

$122.00

52W High

$200.44

50D Avg

$170.12

200D Avg

$170.84

Volume

619.8K

Avg Vol

957.1K

10D Avg Vol

874.3K

52W Change

14.56%

S&P 52W Change

15.30%

Valuation ratios 10 FIELDS

P/E (TTM)

26.18

P/E (Fwd)

12.02

PEG (Fwd)

0.64

P/S

2.59

P/B

2.54

Book Value

$59.41

EV/Revenue

2.35

EV/EBITDA

10.51

Mkt Cap

10.71B

Enterprise Val

9.73B

Profitability & returns 6 FIELDS

Profit Margin

9.99%

Gross Margin

70.74%

Operating Margin

18.25%

EBITDA Margin

22.36%

Return on Assets

7.56%

Return on Equity

10.15%

Growth 3 FIELDS

Revenue Growth (YoY)

4.30%

Earnings Growth (YoY)

-12.10%

Earnings Growth (Q)

-13.10%

Balance sheet & cash flow 11 FIELDS

Total Revenue

4.14B

EBITDA

925.66M

Total Cash

1.1B

Total Debt

120.84M

Cash / Share

$15.52

Revenue / Share

$57.70

Free Cash Flow

594.11M

Operating CF

755.7M

Debt / Equity

2.85

Current Ratio

1.40

Quick Ratio

1.20

Dividend 5 FIELDS

Fwd Dividend

—

Dividend Yield

—

Payout Ratio

0.00%

5Y Avg Yield

—

Ex-Div Date

—

Share statistics 7 FIELDS

Shares Out

71.04M

Float

66.89M

Shares Short

3.86M

% Short of Float

6.20%

Short Ratio

4.37

% Held Insiders

6.13%

% Held Institutions

105.15%

Calendar & events 5 FIELDS

Next Earnings

2026-10-28

Fiscal Year End

2025-12-31

Most Recent Qtr

2026-06-30

Last Split

—

Split Date

—

Company 2 FIELDS

Industry

Medical Instruments & Supplies

Employees

20,435